WuXi AppTec Co Ltd

WuXi AppTec Co Ltd


Company description

About STA

STA Pharmaceutical (STA), a WuXi AppTec company, is a leading small molecule pharmaceutical development and manufacturing capability and technology platform company serving the life science industry, with operations in China and the United States. As a premier Contract Development and Manufacturing Organization (CDMO), STA offers our worldwide partners efficient, flexible and high-quality solutions for small molecule Active Pharmaceutical Ingredients (APIs) and finished dosage forms. End-to-end drug substance services including API development and manufacturing, chemical synthesis route selection, process development and optimization, scale-up process research and is capable of producing intermediates and APIs from kg to metric ton scale. Drug product services include developablity & formulation research, formulation development & optimization, phase I-III clinical supplies including cGMP manufacturing. For more information, please visit http://www.STApharma.com

About WuXi AppTec

WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform company with global operations. As an innovation-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services to help our worldwide customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions. With its industry-leading capabilities in small molecule R&D and manufacturing, biologics R&D and manufacturing, cell therapy and gene therapy R&D and manufacturing, medical device testing, and molecular testing and genomics, WuXi platform is enabling more than 2,000 innovative collaborators from more than 30 countries to bring innovative healthcare products to patients, and to fulfill WuXi’s dream that “every drug can be made and every disease can be treated.”  Please visit http://www.wuxiapptec.com

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity Contract Manufacturer; Manufacturer; Service
Affiliated categories: Advanced Intermediates |Analytical Development |API Contract Manufacturing More

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 7J17 See our Exhibitor Profile   See full Exhibitor List
24 apr 2018

CPhI North America 2018

24-26 April, 2018 Philadelphia, USA We were at stand 519 See our Exhibitor Profile   See full Exhibitor List
24 oct 2017

CPhI Worldwide 2017

24 - 26 October 2017 Messe Frankfurt, Germany We were at stand 61C42 See our Exhibitor Profile   See full Exhibitor List

News about WuXi AppTec Co Ltd

WuXi STA and Dizal Pharmaceutical sign CMC development and manufacturing agreement

24 May 2019

WuXi STA and Dizal Pharmaceutical sign CMC development and manufacturing agreement

WuXi STA will provide integrated CMC services from pre-clinical to commercial, for both API and formulation for Dizal Pharmaceutical research projects.

Read more

25 Feb 2019

Exclusive technology and marketing collaboration for sublingual delivery

WuXi STA will have exclusive access to BioLingus's novel platform to stabilize and deliver sublingually drug targets including small molecules, peptides and proteins, that are currently administered to patients via injection.

Read more

13 Dec 2018

WuXi AppTec expands site in California for pharmaceutical R&D services

Expanded facility will establish a center of excellence in screening, discovery biology, pharmacology, and small molecule process R&D including Phase I GMP manufacturing.

Read more

24 Jul 2018

WuXi STA and Antengene sign development and manufacturing agreement

WuXi STA chosen for its end-to-end CMC platform for new drug development.

Read more
WuXi AppTec Co Ltd

Contact information




View all contact information